Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data

Fig. 2

Riverplot showing treatment sequences. The riverplot outlines sequences of targeted therapies. The width of the bar is proportional to the frequency of each sequence. Molecules can be distinguished by colour. In this diagram treatment lines are defined by a change of molecule. BEVA: bevacizumab; SUNI: sunitinib; TEMS: temsirolimus; AXIT: axitinib; SORA: sorafenib; and EVER: everolimus. Percentages are presented by line of treatment and only for treated patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us